E-LIB Suche - Ergebnisse für: Detalle, Laurent

1

Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α‐Synuc..:

Smit, Johan Willem ; Basile, Peter ; Prato, Maria Key...
Movement Disorders. 37 (2022) 10 - p. 2045-2056 , 2022

Link: https://doi.org/10.1002/..

2

Efficacy and safety of the investigational complement C5 in..:

De Leeuw, Elisabeth ; Van Damme, Karel F. A. ; Declercq, Jozefien...
Respiratory Research. 23 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

3

Results from a Phase 1b Study of UCB0599, an Orally Availab..:

Genius, Just ; Dastros-Pitei, Daniela ; Detalle, Laurent...
Neurology. 96 (2021) 15_supplement - p. , 2021

Link: https://doi.org/10.1212/..

4

Zilucoplan in patients with acute hypoxic respiratory failu..:

Declercq, Jozefien ; Bosteels, Cedric ; Van Damme, Karel...
Trials. 21 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

5

Therapeutic delivery of ALX‐0171 Nanobody reduces disease s..:

Ackermann, Mark ; Alnajjar, Sarhad ; Sitthicharoenchai, Panchan...
The FASEB Journal. 33 (2019) S1 - p. , 2019

Link: https://doi.org/10.1096/..

6

Nanobodies® † †Nanobody is a registered trademark of Ablynx..:

Van Heeke, Gino ; Allosery, Koen ; De Brabandere, Veronique...
Pharmacology & Therapeutics. 169 (2017) - p. 47-56 , 2017

Link: https://doi.org/10.1016/..

7

Generation and Characterization of ALX-0171, a Potent Novel..:

Detalle, Laurent ; Stohr, Thomas ; Palomo, Concepción...
Antimicrobial Agents and Chemotherapy. 60 (2016) 1 - p. 6-13 , 2016

Link: https://doi.org/10.1128/..

8

High Throughput Combinatorial Formatting of PcrV Nanobodies..:

De Tavernier, Evelyn ; Detalle, Laurent ; Morizzo, Erika...
Journal of Biological Chemistry. 291 (2016) 29 - p. 15243-15255 , 2016

Link: https://doi.org/10.1074/..

9

Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strai..:

Larios Mora, Alejandro ; Detalle, Laurent ; Van Geelen, Albert...
PLOS ONE. 10 (2015) 12 - p. e0143580 , 2015

Link: https://doi.org/10.1371/..

10

ALX-0171 toxicity study in RSV-infected cotton rats: Safety..:

Hanton, Gilles ; Detalle, Laurent ; Priem, Sophie...
Toxicology Letters. 211 (2012) - p. S43 , 2012

Link: https://doi.org/10.1016/..

11

Characterization of the T-lymphocyte response elicited by m..:

Detalle, Laurent ; Saxena, Anubha ; Haddou, Nadia Ouled...
Experimental Hematology. 39 (2011) 6 - p. 676-685 , 2011

Link: https://doi.org/10.1016/..

12

Two‐Step Mechanism of Virus‐induced Autoimmune Hemolytic An..:

COUTELIER, JEAN‐PAUL ; DETALLE, LAURENT ; MUSAJI, ANDREI..
Annals of the New York Academy of Sciences. 1109 (2007) 1 - p. 151-157 , 2007

Link: https://doi.org/10.1196/..

13

Enhancement of autoantibody pathogenicity by viral infectio..:

Musaji, Andrei ; Meite, Mory ; Detalle, Laurent...
Autoimmunity Reviews. 4 (2005) 4 - p. 247-252 , 2005

Link: https://doi.org/10.1016/..

14

Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α‐Synuc..:

Smit, Johan Willem ; Basile, Peter ; Prato, Maria Key...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804489/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Efficacy and safety of the investigational complement C5 in..:

De Leeuw, Elisabeth ; Van Damme, Karel F. A ; Declercq, Jozefien...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361275/. , 2022

Link: http://www.ncbi.nlm.nih...